All Stories

  1. Management Strategies Of Idiopathic Anaphylaxis In The Emergency Room: Current Perspectives
  2. Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair® )
  3. Risk of Allergic Conditions in Children Born to Women With Systemic Lupus Erythematosus
  4. Disparities in rate, triggers, and management in pediatric and adult cases of suspected drug-induced anaphylaxis in Canada
  5. Food-induced anaphylaxis to a known food allergen in children often occurs despite adult supervision
  6. Sesame allergy: current perspectives
  7. Anaphylaxis across two Canadian pediatric centers: evaluating management disparities
  8. Anaphylaxis cases presenting to primary care paramedics in Quebec
  9. Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series
  10. Prevalence and Predictors of Food Allergy in Canada: A Focus on Vulnerable Populations
  11. Peanut avoidance and peanut allergy diagnosis in siblings of peanut allergic children
  12. Diagnosis and management of food allergies: new and emerging options: a systematic review
  13. Likelihood of being prescribed an epinephrine autoinjector in allergic Canadians with lower educational levels
  14. A giant sialolith in a 16-year-old boy presenting to the emergency room
  15. Solar urticaria in a 1-year-old infant: diagnosis and management
  16. Friend or foe? Figuring out the difference between FPIES, IgE-mediated allergy and food intolerance
  17. Accidental exposure (AE) to peanut in a large cohort of Canadian children with peanut allergy
  18. A 4-month-old baby boy presenting with anaphylaxis to a banana: a case report
  19. Food-dependent exercise-induced anaphylaxis with negative allergy testing
  20. Possession Of Epinephrine Auto-Injectors (EAI) In a Vulnerable Canadian Population With Food Allergies
  21. Assessing IgE-Mediated Reactions In Children Presenting To An Allergy Clinic With a Suspected Antibiotic Allergy
  22. anaphylaxis in adults
  23. A majority of parents of children with peanut allergy fear using the epinephrine auto-injector
  24. Cold-induced urticaria: challenges in diagnosis and management
  25. Autosomal Dominant Cases of Chronic Mucocutaneous Candidiasis Segregates with Mutations of Signal Transducer and Activator of Transcription 1, But Not of Toll-Like Receptor 3
  26. Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status
  27. The prevalence of food allergy among Aboriginal people in Canada
  28. Autoimmune hemolytic anemia in a teenager: a wolf in sheep's clothing
  29. Critical upper airway obstruction in sporadic angioedema responding to C1-esterase inhibitor
  30. Canadian Allergists' and Nonallergists' Perception of Epinephrine Use and Vaccination of Persons with Egg Allergy
  31. HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy
  32. IgE-mediated cow milk allergy and infantile colic: diagnostic and management challenges
  33. Anaphylaxis in Children Treated At the Montreal Children's Hospital: Rate, Clinical Characteristics, Triggers and Management
  34. Anaphylaxis to ibuprofen in a 12-year-old boy
  35. Altered T Helper 17 Responses in Children with Food Allergy
  36. Demographic Predictors of Peanut, Tree Nut, Fish, Shellfish, and Sesame Allergy in Canada
  37. Oral immunotherapy for milk allergy
  38. Psychosocial factors and chronic spontaneous urticaria: a systematic review
  39. Exploring the Determinants of the Perceived Risk of Food Allergies in Canada
  40. Mannose Binding Lectin Deficiency: More than Meets the Eye
  41. Oral immunotherapy for milk allergy: a systematic review
  42. The use of incentives in vulnerable populations for a telephone survey: a randomized controlled trial
  43. Overall prevalence of self-reported food allergy in Canada
  44. Vitamin D Deficiency/Insufficiency and Challenges in Developing Global Vitamin D Fortification and Supplementation Policy in Adults
  45. Food Allergy: Temporal Trends and Determinants
  46. Effect of precautionary statements on the purchasing practices of Canadians directly and indirectly affected by food allergies
  47. Psychosocial Factors and the Pathogenesis of Chronic Hives: A Survey of Canadian Physicians
  48. Inadvertent exposures in children with peanut allergy
  49. Possession of epinephrine auto-injectors by Canadians with food allergies
  50. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
  51. Impact of Precautionary Statements on Purchasing Practices of Canadians Directly and Indirectly Affected by Food Allergies
  52. Anaphylaxis: past, present and future
  53. Editorial: [Monoclonal Antibodies in the Treatment of Asthma(Guest Editor: Moshe Ben-Shoshan)]
  54. Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions
  55. Establishing the diagnosis of peanut allergy in children never exposed to peanut or with an uncertain history: a cross-Canada study
  56. A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada
  57. Treg function in IPEX
  58. The Predilection of Chickenpox Exanthema to Influenza Vaccine Injection Site
  59. CTLA-4Ig: Uses and Future Directions
  60. Anaphylactic reaction to clarithromycin in a child
  61. Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal
  62. Omalizumab: Not Only For Asthma
  63. Availability of the epinephrine autoinjector at school in children with peanut allergy
  64. F.6. The Use of Confirmatory Testing in the Diagnosis of Peanut Allergy in Children
  65. 1 ,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells
  66. Recurrent meningitis and cerebrospinal fluid leak–two sides of the same vestibulocochlear defect: report of three cases